why choose us

Clinical Trials Search

Showing 18,810 of 132,963 result(s)
Is a Front-of-package Label Contaning Information on Both Nutrient Profil and Ultra-processing Well Understood?

Status: Completed

Condition: Objective Understanding of Nutritional Label

Interventions: Interventional

Date: 2022-10-28

Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG

Status: Completed

Condition: High-Grade Glioma

Interventions: CLR 131 will be administered IV (intravenously) at a dose based on patients' BSA

Date: 2022-10-28

Alcohol Use Disorder and Cannabidiol

Status: Completed

Condition: Alcohol Use Disorder

Interventions: The current study will directly test the hypothesis that a moderate dose of CBD leads to a reduction in alcohol consumption, alcohol craving, peripher

Date: 2022-10-28

Arm and Leg Cycling for Accelerated Recovery From SCI

Status: Completed

Condition: Spinal Cord Injuries

Interventions: The participants will complete 60min of active cycling training paradigm, 5 times a week, for 12 weeks.
The cycling ergometer will be used to pro

Date: 2022-10-28

Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent;Unresectable Endometrial Carcinoma

Status: Completed

Condition: Recurrent Endometrial Carcinoma

Interventions: Lenvatinib capsules taken daily by mouth

Date: 2022-10-28

Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD)

Status: Completed

Condition: Chronic Obstructive Pulmonary Disease

Interventions: MitoQ is a mitochondrial targeted antioxidant that can be obtained over-the-counter.

Date: 2022-10-28

Adaptation of the PCIP for Children Aged 6 to 11

Status: Completed

Condition: Post-Traumatic Stress Disorder in Children

Interventions: This treatment ranges from 1-4 sessions which last 50 minutes per session.
The first session will cover psychoeducation about PTSD symptoms in ch

Date: 2022-10-28

A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer

Status: Completed

Condition: Pancreatic Cancer

Interventions: Patients will receive Tislelizumab (200 mg intravenous) on Day 1 of Cycles 1-6.
Cycle 1 will be 14 days long and occur prior to surgery.
Cyc

Date: 2022-10-28

EaseAlert: Tactile Firefighter Alerting System

Status: Completed

Condition: Heart Rate

Interventions: Description: Standard alerting system in place at the fire station.

Date: 2022-10-28